Govt body's procedures means people with cancer aren't getting drug - AstraZeneca boss

The chief executive of AstraZeneca has criticised a public health body for refusing to make one of its breast cancer treatments available to NHS patients in England and Wales.The National Institute for Health and Care Excellence (NICE) decided in March this year that patients should be denied access to Enhertu because it said the drug did not provide value for money. Money blog:' Major boost' for borrowers as two banks cut mortgage ratesBut Sir Pascal Soriot said he was disappointed at the decision - which ...